The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
Combination therapy: Opportunities and challenges for polymer–drug conjugates as anticancer nanomedicines
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Effect of pegylation on pharmaceuticals
Harris, J. M., & Chess, R. B. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1033 · Cited by 3,431
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
Designing dendrimers for biological applications
Lee, C. C., MacKay, J. A., Fréchet, J. M. J., & Szoka, F. C. (2005) · Nature Biotechnology · doi:10.1038/nbt1171 · Cited by 2,043
Polymer conjugates as anticancer nanomedicines
Duncan, R. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1958 · Cited by 1,962
Monoclonal antibody therapy of cancer
Adams, G. P., & Weiner, L. M. (2005) · Nature Biotechnology · doi:10.1038/nbt1137 · Cited by 1,246
Dendrimer biocompatibility and toxicity
DUNCAN, R., & IZZO, L. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.019 · Cited by 1,158
Polymer Therapeutics: Concepts and Applications
Haag, R., & Kratz, F. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502113 · Cited by 1,115
Structure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094
Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy
Wendel, H.-G., Stanchina, E. D., Fridman, J. S., Malina, A., Ray, S., Kogan, S., Cordon-Cardo, C., Pelletier, J., & Lowe, S. W. (2004) · Nature · doi:10.1038/nature02369 · Cited by 951
(1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-5-448_4 · Cited by 788
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
Polymer–drug conjugates: Progress in polymeric prodrugs
Khandare, J., & Minko, T. (2006) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.09.004 · Cited by 639
Polymer conjugates: nanosized medicines for treating cancer
Vicent, M. J., & Duncan, R. (2006) · Trends in Biotechnology · doi:10.1016/j.tibtech.2005.11.006 · Cited by 443
Self-citationPolymer-drug conjugates: Recent development in clinical oncology
Li, C., & Wallace, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.11.009 · Cited by 436
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Chakraborty, M., Abrams, S. I., Coleman, C. N., Camphausen, K., Schlom, J., & Hodge, J. W. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0073 · Cited by 435
Gnant, M., Mlineritsch, B., Luschin-Ebengreuth, G., Kainberger, F., Kässmann, H., Piswanger-Sölkner, J. C., Seifert, M., Ploner, F., Menzel, C., Dubsky, P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70204-3 · Cited by 396
Gulley, J. L., Arlen, P. M., Bastian, A., Morin, S., Marte, J., Beetham, P., Tsang, K.-Y., Yokokawa, J., Hodge, J. W., Ménard, C., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2062 · Cited by 370
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
Satchi-Fainaro, R., Puder, M., Davies, J. W., Tran, H. T., Sampson, D. A., Greene, A. K., Corfas, G., & Folkman, J. (2004) · Nature Medicine · doi:10.1038/nm1002 · Cited by 345
Star and Hyperbranched Polymers
Kobayashi, S., & Mishra, M. (1999) · Medical Entomology and Zoology · Cited by 281
Meerum Terwogt, J. M., ten Bokkel Huinink, W. W., Schellens, J. H., Schot, M., Mandjes, I. A., Zurlo, M. G., Rocchetti, M., Rosing, H., Koopman, F. J., & Beijnen, J. H. (2001) · Anti-Cancer Drugs · doi:10.1097/00001813-200104000-00003 · Cited by 279
In vitro biological evaluation of high molecular weight hyperbranched polyglycerols
Kainthan, R. K., Hester, S. R., Levin, E., Devine, D. V., & Brooks, D. E. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.07.011 · Cited by 273
Minko, T., Kopečková, P., Pozharov, V., & Kopeček, J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00009-1 · Cited by 243
Lammers, T., Subr, V., Ulbrich, K., Peschke, P., Huber, P. E., Hennink, W. E., & Storm, G. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.040 · Cited by 240
Muggia, F. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.09.034 · Cited by 221
Paclitaxel poliglumex (XYOTAX™, CT-2103): A macromolecular taxane
Singer, J. W. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.033 · Cited by 213
Langer, C. J., O’Byrne, K. J., Socinski, M. A., Mikhailov, S. M., Leśniewski-Kmak, K., Smakal, M., Ciuleanu, T. E., Orlov, S. V., Dediu, M., Heigener, D., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181753b4b · Cited by 202
Polymer Therapeutics Designed for a Combination Therapy of Hormone‐Dependent Cancer
Vicent, M. J., Greco, F., Nicholson, R. I., Paul, A., Griffiths, P. C., & Duncan, R. (2005) · Angewandte Chemie International Edition · doi:10.1002/anie.200462960 · Cited by 199
Self-citationDuncan, R., Gac-Breton, S., Keane, R., Musila, R., Sat, Y. N., Satchi, R., & Searle, F. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00328-5 · Cited by 195
Suarez-Pinzon, W. L., Power, R. F., Yan, Y., Wasserfall, C., Atkinson, M., & Rabinovitch, A. (2008) · Diabetes · doi:10.2337/db08-0688 · Cited by 187
Preclinical evaluation of polymer-bound doxorubicin
Duncan, R., Seymour, L. W., O'Hare, K. B., Flanagan, P. A., Wedge, S., Hume, I. C., Ulbrich, K., Strohalm, J., Subr, V., Spreafico, F., et al. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90088-9 · Cited by 187
Miller, K., Erez, R., Segal, E., Shabat, D., & Satchi‐Fainaro, R. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805133 · Cited by 179
Bae, Y., Diezi, T. A., Zhao, A., & Kwon, G. S. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.05.038 · Cited by 173
Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin
Satchi-Fainaro, R., Mamluk, R., Wang, L., Short, S. M., Nagy, J. A., Feng, D., Dvorak, A. M., Dvorak, H. F., Puder, M., Mukhopadhyay, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.007 · Cited by 173
Polymeric site-specific pharmacotherapy
(1995) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(95)90022-5 · Cited by 164
Fang, J. Q., Sawa, T., Akaike, T., Greish, K. F., & Maeda, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11644 · Cited by 157
Synthesis and in Vivo Antitumor Activity of Poly( l -glutamic acid) Conjugates of 20(S)-Camptothecin
Bhatt, R., de Vries, P. W., Tulinsky, J., Bellamy, G., Baker, B., Singer, J. W., & Klein, P. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020022r · Cited by 152
HIV infection, HAART, and endothelial adhesion molecules: current perspectives
Donati, K. D. G., Ricardo Rabagliati, B., Iacoviello, L., & Cauda, R. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)00971-5 · Cited by 147
Polymer Therapeutics for Cancer: Current Status and Future Challenges
Satchi‐Fainaro, R., Duncan, R., & Barnés, C. M. (2005) · Springer eBooks · doi:10.1007/12_024 · Cited by 146
Designer combination therapy for cancer
Lane, D. P. (2006) · Nature Biotechnology · doi:10.1038/nbt0206-163 · Cited by 145
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy
Lammers, T., Šubr, V., Peschke, P., Kühnlein, R., Hennink, W. E., Ulbrich, K., Kiessling, F. M., Heilmann, M., Debus, J., Huber, P. E., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604561 · Cited by 141
Schlüter, A. D. (2005) · Topics in current chemistry · doi:10.1007/b98168 · Cited by 136
PDEPT: polymer-directed enzyme prodrug therapy
Satchi, R., Connors, T. A., & Duncan, R. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2026 · Cited by 132
DUNCAN, R., Seymour, L. W., Scarlett, L., LLOYD, J., Rejmanová, P., & Kopeček, J. (1986) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(86)90120-0 · Cited by 130
Chipman, S. D., Oldham, F. B., Pezzoni, G., & Singer, J. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.4.375 · Cited by 125
Lammers, T., Peschke, P., Kühnlein, R., Subr, V., Ulbrich, K., Debus, J., Huber, P., Hennink, W., & Storm, G. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.032 · Cited by 124
Targeting Angiogenesis-Dependent Calcified Neoplasms Using Combined Polymer Therapeutics
Segal, E., Pan, H., Ofek, P., Udagawa, T., Kopečková, P., Kopec̆ek, J., & Satchi‐Fainaro, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005233 · Cited by 116
Anticancer therapeutics: “Addictive” targets, multi-targeted drugs, new drug combinations
Broxterman, H. J., & Georgopapadakou, N. H. (2005) · Drug Resistance Updates · doi:10.1016/j.drup.2005.07.002 · Cited by 113
Polymer-drug conjugates: current status and future trends
Greco, F., & Vicent, M. J. (2007) · Frontiers in bioscience · doi:10.2741/2882 · Cited by 113
Self-citationBevacizumab in the Treatment of Breast Cancer: Rationale and Current Data
Rugo, H. S. (2004) · The Oncologist · doi:10.1634/theoncologist.9-suppl_1-43 · Cited by 108
Shiah, J.-G., Sun, Y., Kopečková, P., Peterson, C. M., Straight, R. C., & Kopec̆ek, J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00325-x · Cited by 105
HPMA-based polymer conjugates with drug combination
Krakovičová, H., Etrych, T., & Ulbrich, K. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.03.011 · Cited by 99
Satchi‐Fainaro, R., Hailu, H., Davies, J. W., Summerford, C., & Duncan, R. (2003) · Bioconjugate Chemistry · doi:10.1021/bc020091k · Cited by 94
Greco, F., Vicent, M. J., Gee, S., Jones, A. T., Gee, J. M. W., Nicholson, R. I., & Duncan, R. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.012 · Cited by 90
Self-citationPEG-epirubicin Conjugates with High Drug Loading
Pasut, G., Scaramuzza, S., Schiavon, O., Mendichi, R., & Veronese, F. M. (2005) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911505053377 · Cited by 87
Peptide and protein PEGylation III: advances in chemistry and clinical applications
Veronese, F. M., & Harris, J. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.003 · Cited by 87
Polymer conjugates as therapeutics: future trends, challenges and opportunities
Vicent, M. J., Dieudonne, L., Carbajo, R. J., & Pineda‐Lucena, A. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.5.593 · Cited by 86
Self-citationNovel Polymeric Prodrug with Multivalent Components for Cancer Therapy
Khandare, J. J., Chandna, P., Wang, Y., Pozharov, V. P., & Minko, T. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.098855 · Cited by 83
IHOVA, B. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00235-9 · Cited by 77
Hentschel, J., ten Cate, M. G. J., & Börner, H. G. (2007) · Macromolecules · doi:10.1021/ma071810z · Cited by 75
Paclitaxel Poliglumex (PPX-Xyotax) and Concurrent Radiation for Esophageal and Gastric Cancer
DiPetrillo, T. A., Milas, L., Evans, D. L., Akerman, P., Ng, T., Miner, T., Cruff, D., Chauhan, B., Iannitti, D. A., Harrington, D. T., et al. (2006) · American Journal of Clinical Oncology · doi:10.1097/01.coc.0000224494.07907.4e · Cited by 74
Hongrapipat, J., Kopečková, P., Liu, J., Prakongpan, S., & Kopec̆ek, J. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800006e · Cited by 70
Šírová, M., Strohalm, J., Šubr, V., Plocová, D., Rossmann, P., Mrkvan, T., Ulbrich, K., & Říhová, B. (2006) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-006-0168-0 · Cited by 65
Griffiths, P. C., Paul, A., Khayat, Z., Wan, K., King, S. M., Grillo, I., Schweins, R., Ferruti, P., Franchini, J., & Duncan, R. (2004) · Biomacromolecules · doi:10.1021/bm049936g · Cited by 56
Vicent, M. J., & Pérez‐Payá, E. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060458x · Cited by 52
Self-citationPaul, A., Vicent, M. J., & Duncan, R. (2007) · Biomacromolecules · doi:10.1021/bm060925s · Cited by 52
Self-citationHonecker, F. U., Kollmannsberger, C., Quietzsch, D., Haag, C., Schroeder, M. P., Spott, C., Hartmann, J. T., Baronius, W., Hempel, V., Kanz, L., et al. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200206000-00008 · Cited by 52
HER-2-positive metastatic breast cancer: trastuzumab and beyond
Metro, G., Mottolese, M., & Fabi, A. (2008) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.9.15.2583 · Cited by 49
Verschraegen, C. F., Skubitz, K. M., DAUD, A. I., Kudelka, A. P., Rabinowitz, I., Allievi, C., Eisenfeld, A. J., Singer, J. W., & Oldham, F. B. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0813-8 · Cited by 46
Santucci, L., Mencarelli, A., Renga, B., Pasut, G., Veronese, F. M., Zacheo, A., Germani, A., & Fiorucci, S. (2006) · The FASEB Journal · doi:10.1096/fj.05-4452fje · Cited by 46
N-(2-Hydroxypropyl)methacrylamide Copolymer Conjugates
Duncan, R. (2005) · CRC Press eBooks · doi:10.1201/9780849348129-4 · Cited by 44
Dendritic systems in drug delivery applications
Jain, N. K., & Asthana, A. (2007) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.4.5.495 · Cited by 37
HPMA copolymer–aminoglutethimide conjugates inhibit aromatase in MCF-7 cell lines
Greco, F., Vicent, M. J., Penning, N. A., Nicholson, R. I., & Duncan, R. (2005) · Journal of drug targeting · doi:10.1080/10611860500383788 · Cited by 36
Self-citationTherapeutic Strategy for Treatment of Metastatic Non-Small Cell Lung Cancer
Berhoune, M., Banu, E., Scotté, F., Prognon, P., Oudard, S. M., & Bonan, B. (2008) · Annals of Pharmacotherapy · doi:10.1345/aph.1l200 · Cited by 30
Tanabe, M., Ito, Y., Tokudome, N., Sugihara, T., Miura, H., Takahashi, S., Seto, Y., Iwase, T., & Hatake, K. (2009) · Breast Cancer · doi:10.1007/s12282-009-0093-0 · Cited by 28
Terapia combinada como estrategia en la prevención de la resistencia a los antimaláricos.
Orjuela-Sánchez, P., González, I. J., & Osório, L. (2004) · Biomédica · doi:10.7705/biomedica.v24i4.1292 · Cited by 17
Avastin-Tarceva combination fails in lung cancer
Jones, D. R. (2009) · Nature Biotechnology · doi:10.1038/nbt0209-108 · Cited by 12
Cited by
Targeted polymeric therapeutic nanoparticles: design, development and clinical translation
Kamaly, N., Xiao, Z., Valencia, P. M., Radovic-Moreno, A. F., & Farokhzad, O. C. (2012) · Chemical Society Reviews · doi:10.1039/c2cs15344k · Cited by 1,730
Ulbrich, K., Holá, K., Šubr, V., Bakandritsos, A., Tuček, J., & Zbořil, R. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00589 · Cited by 1,730
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Shi, J., Votruba, A. R., Farokhzad, O. C., & Langer, R. (2010) · Nano Letters · doi:10.1021/nl102184c · Cited by 1,612
Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress
Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324
Nanomedicine(s) under the Microscope
Duncan, R., & Gaspar, R. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200394t · Cited by 981
Metadata
- Authors
- Greco, F., & Vicent, M. J.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2009-11
- Volume
- 61
- Issue
- 13
- Pages
- 1203-1213
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2000691433
- Cited by
- 652
- References
- 78
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.